Cerus (CERS) Assets Average (2011 - 2026)
Cerus (CERS) reported Assets Average of $222.4 million for Q1 2026, up 9.09% on a YoY basis from $203.8 million in Q1 2025, and up 1.77% sequentially from $218.5 million in Q4 2025.
Cerus (CERS) Assets Average (2011 - 2026) Analysis & Trends
Cerus (CERS) has 16 years of Assets Average data on file, last reported at $222.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 9.09% year-over-year to $222.4 million; the trailing twelve-month figure through Mar 2026 stood at $222.4 million (up 9.09% YoY), and the FY2025 full-year result was $211.4 million, up 6.05% from the prior year.
- Assets Average advanced to $222.4 million in Q1 2026, from $218.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $229.7 million in Q1 2022 to a low of $187.3 million in Q2 2024.
- A 5-year average of $208.0 million and a median of $209.9 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average dropped 9.49% in 2024 and rose 14.19% in 2025, its largest moves.
- Tracing CERS's Assets Average over 5 years: stood at $216.7 million in 2022, then decreased by 6.9% to $201.8 million in 2023, then retreated by 3.25% to $195.2 million in 2024, then grew by 11.93% to $218.5 million in 2025, then rose by 1.77% to $222.4 million in 2026.
- Business Quant data shows CERS's Assets Average at $222.4 million in Q1 2026, $218.5 million in Q4 2025, and $214.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 6.49 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 37.02 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 10.57 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 31.64 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 222.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222.38 Mn |
| Dec 31, 2025 | 218.52 Mn |
| Sep 30, 2025 | 214.13 Mn |
| Jun 30, 2025 | 209.92 Mn |
| Mar 31, 2025 | 203.85 Mn |
| Dec 31, 2024 | 195.23 Mn |
| Sep 30, 2024 | 187.52 Mn |
| Jun 30, 2024 | 187.32 Mn |
| Mar 31, 2024 | 193.44 Mn |
| Dec 31, 2023 | 201.80 Mn |
| Sep 30, 2023 | 202.35 Mn |
| Jun 30, 2023 | 204.10 Mn |
| Mar 31, 2023 | 213.71 Mn |
| Dec 31, 2022 | 216.75 Mn |
| Sep 30, 2022 | 215.93 Mn |
| Jun 30, 2022 | 219.18 Mn |
| Mar 31, 2022 | 229.70 Mn |
| Dec 31, 2021 | 228.22 Mn |
| Sep 30, 2021 | 221.08 Mn |
| Jun 30, 2021 | 221.90 Mn |